相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix A case report
Yong Wang et al.
MEDICINE (2020)
CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas
Jung Han Woo et al.
SCIENTIFIC REPORTS (2020)
Female genital tract metastasis of lung adenocarcinoma with EGFR mutations: Report of two cases
Run-Lan Yan et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Factors Associated With Distant Metastasis in EGFR-mutated Non-small Cell Lung Cancer Patients: Logistic Analysis
Hiroko Watanabe et al.
IN VIVO (2019)
Uterine metastasis of lung adenocarcinoma under molecular target therapy with epidermal growth factor receptor tyrosine kinase inhibitors: A case report and review of the literature
Mayu Shibata et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2018)
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T79OM-Positive Lung Cancer and Acquired Resistance to Osimertinib
Geoffrey R. Oxnard et al.
JAMA ONCOLOGY (2018)
Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China
Hongwei Li et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan
Jian Guan et al.
MEDICAL ONCOLOGY (2016)
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Glenwood Goss et al.
LANCET ONCOLOGY (2016)
Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer
David C. L. Lam et al.
CLINICAL LUNG CANCER (2015)
Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib
Yan Xu et al.
CANCER BIOLOGY & THERAPY (2010)
分享论文
